Skip to main content

Advertisement

Table 3 Fatty acid profile of plasma in control and AD* patients

From: The sociodemographic characteristics and dietary and blood plasma fatty acid profiles of elderly Saudi women with Alzheimer disease

Fatty acid from plasma (g/day) National Guard Health Affairs- King Abdulaziz Medical City, Riyadh (NGH) Social Welfare Homes for the Elderly (SWH)
  Control Alzheimer Control Alzheimer
LA (Linoleic acid; C18:2) 2.423 ± 0.1532Aa 1.554 ± 0.1500Aa 1.899 ± 1.001Aa 01.756 ± 0.1080Aa
AA (Arachidonic acid; C20:4) 0.019 ± 0.0007Aa 0.002 ± 0.018Aa 0.017 ± 0.001Aa 0.017 ± 0.001Aa
ALA (α-linolenic acid; C18:3) 18.17 ± 1.165Aa 11.57 ± 1.1400Aa 14.24 ± 0.7520Aa 13.19 ± 0.8085Aa
EPA (Eicosapentaenoic acid; C20:5) 0.158 ± 0.0172Aa 0.111 ± 0.0086Aab 0.109 ± 0.0067Aab 0.083 ± 0.0032Ab
DHA (Docosahexaenoic acid; C22:6) 0.460 ± 0.0421Aa 0.377 ± 0.0360Aa 0.352 ± 0.0206Aa 0.403 ± 0.0226Aa
Total ω-6 2.442 ± 0.1536Aa 1.572 ± 0.1501Aa 1.916 ± 0.1001Aa 1.773 ± 0.1080Aa
Total ω-3 18.78 ± 11.95 Aa 12.05 ± 1.1738Aa 14.71 ± 0.7710Aa 13.68 ± 0.8284Aa
ω-6/ ω-3 0.137 ± 0.0021Ab 0.174 ± 0.0102Aa 0.130 ± 0.004Ab 0.006 ± 0.12Ab
  1. *AD-Alzheimer disease
  2. Results are reported in mean ± standard deviation
  3. abDifferent superscripts denote a statistically significant difference between controls of two different places and between Alzheimer patients of two places
  4. A superscripts denote a statistically significant difference between controls and Alzheimers patients of each place individually